Collision tumors of the thyroid. A special clinical and pathological entity
Abstract
##plugins.themes.bootstrap3.article.details##
cancer, thyroid, collision tumors
2. Thomas A, Mittal N, Rane SU, et al. Papillary and medullary thyroid carcinomas presenting as collision tumors: a case series of 21 cases at a tertiary care cancer center. Head Neck Pathol. 2021; 15(4):1137-1146. https://doi.org/10.1007/s12105-021-01323-7
3. Volante M, Papotti M, Roth J, et al. Mixed medullary-follicular thyroid carcinoma. Am J Pathol. 1999; 155(5):1499-1509. https://doi.org/10.1016/S0002-9440(10)65465-X
4. Walvekar RR, Kane SV, DCruz AK. Collision tumor of the thyroid: follicular variant of papillary carcinoma and squamous carcinoma. World J Surg Oncol. 2006; 4:65. https://doi.org/10.1186/1477-7819-4-65
5. Plauche V, Dewenter T, Walvekar RR. Follicular and papillary carcinoma: a thyroid collision tumor. Indian J Otolaryngol Head Neck Surg. 2013; 65(Suppl 1):182-184. https://doi.org/10.1007/s12070-011-0450-0
6. Cichoń S, Anielski R, Konturek A, Barczyński M, Cichoń W. Metastases to the thyroid gland: seventeen cases operated on in a single clinical center. Langenbecks Arch Surg. 2006; 391(6):581-587. https://doi.org/10.1007/s00423-006-0081-1
7. Pastorello RG, Saieg MA. Metastases to the thyroid: potential cytologic mimics of primary thyroid neoplasms. Arch Pathol Lab Med. 2018; 143(3):394-399. https://doi.org/10.5858/arpa.2017-0570-RS
8. Koufopoulos N, Zacharatou A, Gouloumis A-R, et al. Metastatic thyroid osteosarcoma with concomitant multifocal papillary carcinoma presenting as a collision tumor. Cureus. 2021; 13(6):e15425. https://doi.org/10.7759/cureus.15425
9. Chung AY, Tran TB, Brumund KT, Weisman RA, Bouvet M. Metastases to the thyroid: a review of the literature from the last decade. Thyroid Off J Am Thyroid Assoc. 2012; 22(3):258-268. https://doi.org/10.1089/thy.2010.0154
10. Ryan N, Walkden G, Lazic D, Tierney P. Collision tumors of the thyroid: a case report and review of the literature. Head Neck. 2015; 37(10):E125-129. https://doi.org/10.1002/hed.23936
11. Rossi ED, Pantanowitz L, Hornick JL. A worldwide journey of thyroid cancer incidence centred on tumour histology. Lancet Diabetes Endocrinol. 2021; 9(4):193-194. https://doi.org/10.1016/S2213-8587(21)00049-8
12. Sadow PM, Hunt JL. Mixed medullary-follicular-derived carcinomas of the thyroid gland. Adv Anat Pathol. 2010; 17(4):282-285. https://doi.org/10.1097/PAP.0b013e3181e4ab3e
13. Biscolla RP, Ugolini C, Sculli M, et al. Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behavior. Thyroid. 2004; 14(11):946-952. https://doi.org/10.1089/thy.2004.14.946
14. Wong RL, Kazaure HS, Roman SA, Sosa JA. Simultaneous medullary and differentiated thyroid cancer: a population-level analysis of an increasingly common entity. Ann Surg Oncol. 2012; 19(8):2635-2642. https://doi.org/10.1245/s10434-012-2357-8
15. Rossi S, Fugazzola L, De Pasquale L, et al. Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumour: report of three cases with molecular analysis and review of the literature. Endocr Relat Cancer. 2005; 12(2):281-289. https://doi.org/10.1677/erc.1.00901
16. Pishdad R, Cespedes L, Boutin R, Jaloudi M, Raghuwanshi M. Coexistence of two different thyroid malignancies: a collision phenomenon. Cureus. 2020; 12(4):e7539. https://doi.org/10.7759/cureus.7539
17. Kim WG, Gong G, Kim EY, et al. Concurrent occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma in the same thyroid should be considered as coincidental. Clin Endocrinol (Oxf). 2010; 72(2):256-263. https://doi.org/10.1111/j.1365-2265.2009.03622.x
18. Nabili V, Natarajan S, Hirschovitz S, Bhuta S, Abemayor E. Collision tumor of thyroid: metastatic lung adenocarcinoma plus papillary thyroid carcinoma. Am J Otolaryngol. 2007; 28(3):218-220. https://doi.org/10.1016/j.amjoto.2006.08.002
19. Toyoshima MTK, Domingues RB, Soares IC, et al. Thyroid collision tumor containing oncocytic carcinoma, classical and hobnail variants of papillary carcinoma and areas of poorly differentiated carcinoma. Arch Endocrinol Metab. 2021; 65(4):495-499. https://doi.org/10.20945/2359-3997000000389
20. Warman M, Lipschitz N, Ikher S, Halperin D. Collision tumor of the thyroid gland: primary squamous cell and papillary thyroid carcinoma. ISRN Otolaryngol. 2011; 2011:582374. https://doi.org/10.5402/2011/582374
21. Soror NN, Shah P, Hemrock L, Bennett R. Primary squamous cell carcinoma of the thyroid: a case report and literature review about a rare entity. Cureus. 2021; 13(5):e14963. https://doi.org/10.7759/cureus.14963
22. Sokoya M, Thomas CM, Eustaquio M. A rare collision tumor: tracheal sarcomatoid carcinoma invading a papillary thyroid carcinoma. Open Access Libr. J 2017; 4(12):1-6. https://doi.org/10.4236/oalib.1104012
23. Booya F, Sebo TJ, Kasperbauer JL, Fatourechi V. Primary squamous cell carcinoma of the thyroid: report of ten cases. Thyroid. 2006; 16(1):89-93. https://doi.org/10.1089/thy.2006.16.89
24. Gul K, Ozdemir D, Ugras S, Inancli SS, Ersoy R, Cakir B. Coexistent familial nonmultiple endocrine neoplasia medullary thyroid carcinoma and papillary thyroid carcinoma associated with RET polymorphism. Am J Med Sci. 2010; 340(1):60-63. https://doi.org/10.1097/MAJ.0b013e3181dfb245
25. Kleer CG, Giordano TJ, Merino MJ. Squamous cell carcinoma of the thyroid: an aggressive tumor associated with tall cell variant of papillary thyroid carcinoma. Mod Pathol. 2000; 13(7):742-746. https://doi.org/10.1038/modpathol.3880129
26. Darwish A, Satir AA, Hameed T, Malik S, Aqel N. Simultaneous medullary carcinoma, occult papillary carcinoma and lymphocytic thyroiditis. Malays J Pathol. 1995; 17(2):103-107.
27. Ljungberg O, Ericsson UB, Bondeson L, Thorell J. A compound follicular-parafollicular cell carcinoma of the thyroid: a new tumor entity? Cancer. 1983; 52(6):1053-1061. https://doi.org/10.1002/1097-0142(19830915)52:6<1053::aid-cncr2820520621>3.0.co;2-q
28. Gurkan E, Gurbuz Y, Tarkun I, Canturk Z, Cetinarslan B. Mixed medullary-papillary carcinoma of the thyroid: report of two cases and review of the literature. Indian J Pathol Microbiol. 2014; 57(4):598-602. https://doi.org/10.4103/0377-4929.142684
29. Dikbas O, Duman AA, Guvendi GF. Medullary thyroid carcinoma and papillary thyroid carcinoma in the same patient as a collision tumour. Case Rep Endocrinol. 2019; 2019:4038628. https://doi.org/10.1155/2019/4038628
30. Brauckhoff M, Gimm O, Hinze R, Ukkat J, Brauckhoff K, Dralle H. Papillary thyroid carcinoma in patients with ret proto-oncogene germline mutation. Thyroid. 2002; 12(7):557-561. https://doi.org/10.1089/105072502320288393
31. Bounacer A, Wicker R, Caillou B, et al. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene. 1997; 15(11):1263-1273. https://doi.org/10.1038/sj.onc.1200206
32. Ball DW. Medullary thyroid cancer: therapeutic targets and molecular markers. Curr Opin Oncol. 2007; 19(1):18-23. https://doi.org/10.1097/CCO.0b013e32801173ea
33. Vantyghem M-C, Pigny P, Leteurtre E, et al. Thyroid carcinomas involving follicular and parafollicular C cells: seventeen cases with characterization of RET oncogenic activation. Thyroid Off J Am Thyroid Asso.c 2004; 14(10):842-847. https://doi.org/10.1089/thy.2004.14.842
34. Weinhaeusel A, Scheuba C, Lauss M, et al. The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma. Thyroid Off J Am Thyroid Assoc. 2008; 18(12):1269-1276. https://doi.org/10.1089/thy.2008.0139.
Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.
Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.
Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.